WO2009065946A3 - Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition - Google Patents

Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition Download PDF

Info

Publication number
WO2009065946A3
WO2009065946A3 PCT/EP2008/066032 EP2008066032W WO2009065946A3 WO 2009065946 A3 WO2009065946 A3 WO 2009065946A3 EP 2008066032 W EP2008066032 W EP 2008066032W WO 2009065946 A3 WO2009065946 A3 WO 2009065946A3
Authority
WO
WIPO (PCT)
Prior art keywords
component
oil
minerals
mixtures
components
Prior art date
Application number
PCT/EP2008/066032
Other languages
German (de)
French (fr)
Other versions
WO2009065946A2 (en
Inventor
Axel Siegner
Original Assignee
Neopharmacie Gmbh
Axel Siegner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neopharmacie Gmbh, Axel Siegner filed Critical Neopharmacie Gmbh
Priority to AP2010005275A priority Critical patent/AP2010005275A0/en
Priority to EP08852749A priority patent/EP2259789A2/en
Publication of WO2009065946A2 publication Critical patent/WO2009065946A2/en
Publication of WO2009065946A3 publication Critical patent/WO2009065946A3/en
Priority to ZA2010/03574A priority patent/ZA201003574B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Abstract

The invention relates to a pharmaceutical kit which consists of at least two spatially separate compositions 1 and 2, pharmaceutical composition 1 containing an aqueous emulsion of components A, B, C and optionally D and E, the total weight of which adds up to 100 wt.-%, a) 1 - 59.9 wt.-% of at least one mineral oil, silicon oil, plant oil or a mixture thereof, as component A, b) 40 - 98.9 wt.-% of water as component B, c) 0.1 - 30 wt.-% of at least one emulsifier as component C, d) 0 - 20 wt.-% of at least one stabilizer, selected from monovalent or polyvalent alcohols, polysaccharides, minerals and mixtures thereof as component D, e) 0 - 58.9 wt.-% of physiologically acceptable substances, selected from minerals, vitamins, nutrients or mixtures thereof as component E; pharmaceutical composition 2 in solid or mixed solid/liquid form, containing at least one of components F, G and H, the total weight of which adds up to 100 wt.-%, f) 0 - 100 wt.-% of physiologically acceptable substances, selected from minerals, vitamins, nutrients or mixtures thereof as component F, g) 0 - 100 wt.-% of at least one pharmacologically acceptable solid carrier as component G, h) 0 - 100 wt.-% of at least one pharmacologically acceptable active substance as component H, wherein up to 50 wt.-% of components F and H may be present in liquid form.
PCT/EP2008/066032 2007-11-23 2008-11-21 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition WO2009065946A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AP2010005275A AP2010005275A0 (en) 2007-11-23 2008-11-21 Pharmaceutical kit consisting of an oil-in water emulsion and a solid composition
EP08852749A EP2259789A2 (en) 2007-11-23 2008-11-21 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition
ZA2010/03574A ZA201003574B (en) 2007-11-23 2010-05-20 Pharmaceutical kit consisting of an oil-water emulsion and a solid composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007056424.6 2007-11-23
DE102007056424A DE102007056424A1 (en) 2007-11-23 2007-11-23 Pharmaceutical composition containing an oil / water emulsion

Publications (2)

Publication Number Publication Date
WO2009065946A2 WO2009065946A2 (en) 2009-05-28
WO2009065946A3 true WO2009065946A3 (en) 2009-07-16

Family

ID=40457343

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/EP2008/066032 WO2009065946A2 (en) 2007-11-23 2008-11-21 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition
PCT/EP2008/066033 WO2009065947A2 (en) 2007-11-23 2008-11-21 Pharmaceutical composition containing a zeolite/algae or zeolite/emulsion combination for the treatment of aids

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/066033 WO2009065947A2 (en) 2007-11-23 2008-11-21 Pharmaceutical composition containing a zeolite/algae or zeolite/emulsion combination for the treatment of aids

Country Status (6)

Country Link
EP (1) EP2259789A2 (en)
AP (2) AP2010005274A0 (en)
DE (1) DE102007056424A1 (en)
RU (2) RU2496506C2 (en)
WO (2) WO2009065946A2 (en)
ZA (2) ZA201003574B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2545788A1 (en) * 2011-07-13 2013-01-16 Martin Hulliger Dietary multi-component system
RU2708161C1 (en) * 2019-04-16 2019-12-05 Иван Павлович Уваров Fodder complex biologically active additive for animals and birds

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
WO1999047141A1 (en) * 1998-03-16 1999-09-23 The Procter & Gamble Company Method of treating skin irritation
US20030216364A1 (en) * 2001-08-13 2003-11-20 Johnson Keith Arthur Dermatological Formulation
US20040253323A1 (en) * 2003-06-11 2004-12-16 Giles Brian C. Ionic cancer therapy and methods for using same in the treatment of tumors and metastasis
US20060100165A1 (en) * 2003-04-24 2006-05-11 Galderma S.A. Topical application of ivermectin for the treatment of dermatological conditions/afflictions
WO2006089537A1 (en) * 2005-02-25 2006-08-31 Heinrich Exner Method for production of a preparation of a solid dmso-containing silicone oil emulsion for the binding of reactive oxygen compounds in human and animal bodies
WO2007060171A1 (en) * 2005-11-22 2007-05-31 Nestec S.A. Easily dispersible lipidic phase
WO2007091016A1 (en) * 2006-02-08 2007-08-16 Croda International Plc Emulsification systems, emulsions and wet wipes containing such emulsions
WO2007098186A2 (en) * 2006-02-22 2007-08-30 Novavax, Inc. Adjuvant and vaccine compositions
WO2007103294A2 (en) * 2006-03-07 2007-09-13 Novavax, Inc. Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19940011B4 (en) * 1999-08-24 2009-04-02 Schütte/Reichel GbR (vertretungsberechtigte Gesellschafter: Irene Schütte Alginate preparation and their use
US20060122082A1 (en) * 2000-02-17 2006-06-08 Leonard Paul Foam/spray producing compositions and dispensing system therefor
US20050058672A1 (en) * 2003-09-14 2005-03-17 Bioderm Research Baby Care Skin Protectant Compositions for Diaper Rash
US7485451B2 (en) * 2004-11-18 2009-02-03 Regents Of The University Of California Storage stable compositions of biological materials
US20070031512A1 (en) * 2005-08-03 2007-02-08 Amcol International Corporation Virus-interacting layered phyllosilicates and methods of inactivating viruses
BRPI0616076A2 (en) * 2005-09-16 2011-06-07 Dsm Ip Assets Bv particulate lipid pharmaceutical composition
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
WO1999047141A1 (en) * 1998-03-16 1999-09-23 The Procter & Gamble Company Method of treating skin irritation
US20030216364A1 (en) * 2001-08-13 2003-11-20 Johnson Keith Arthur Dermatological Formulation
US20060100165A1 (en) * 2003-04-24 2006-05-11 Galderma S.A. Topical application of ivermectin for the treatment of dermatological conditions/afflictions
US20040253323A1 (en) * 2003-06-11 2004-12-16 Giles Brian C. Ionic cancer therapy and methods for using same in the treatment of tumors and metastasis
WO2006089537A1 (en) * 2005-02-25 2006-08-31 Heinrich Exner Method for production of a preparation of a solid dmso-containing silicone oil emulsion for the binding of reactive oxygen compounds in human and animal bodies
WO2007060171A1 (en) * 2005-11-22 2007-05-31 Nestec S.A. Easily dispersible lipidic phase
WO2007091016A1 (en) * 2006-02-08 2007-08-16 Croda International Plc Emulsification systems, emulsions and wet wipes containing such emulsions
WO2007098186A2 (en) * 2006-02-22 2007-08-30 Novavax, Inc. Adjuvant and vaccine compositions
WO2007103294A2 (en) * 2006-03-07 2007-09-13 Novavax, Inc. Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same

Also Published As

Publication number Publication date
RU2010125505A (en) 2011-12-27
WO2009065947A3 (en) 2009-11-19
ZA201003573B (en) 2011-04-28
ZA201003574B (en) 2011-02-23
RU2496506C2 (en) 2013-10-27
WO2009065946A2 (en) 2009-05-28
RU2010125503A (en) 2011-12-27
EP2259789A2 (en) 2010-12-15
WO2009065947A2 (en) 2009-05-28
DE102007056424A1 (en) 2009-05-28
AP2010005274A0 (en) 2010-06-30
AP2010005275A0 (en) 2010-06-30

Similar Documents

Publication Publication Date Title
ATE496609T1 (en) IMPROVED OIL DELIVERY FROM STRUCTURED SURFACTANT FORMULATIONS
EP2123257A3 (en) Stable high Vitamin C content polyol-in-oil emulsified system and its preparation
MA40571A (en) COMPOSITION COMPRISING A MIXTURE OF PLANT EXTRACTS OR A MIXTURE OF MOLECULES CONTAINED IN THESE PLANTS AND USE TO ACT ON CARBOHYDRATE AND / OR LIPID METABOLISM
WO2006110862A3 (en) Micelle composition of polymer and passenger drug
WO2010108085A3 (en) Personal-care composition comprising oil-soluble solid sunscreens
WO2008064353A3 (en) 7,8-saturated-4,5-epoxy-morphinanium analogs
WO2012035015A3 (en) Composition containing a pyripyropene insecticide and an adjuvant
WO2006037089A3 (en) Low oil emulsion compositions for delivering taxoids and other insoluble drugs
WO2008070462A3 (en) N-oxides of 4,5-epoxy-morphinanium analogs
WO2009101113A3 (en) Oil-in-water emulsion comprising an amphiphilic polymer
WO2008037377A3 (en) Agrochemical formulations that can be dispersed in water containing polyalkoxytriglycerides as penetration enhances
WO2011154905A3 (en) Colored aqueous cosmetic compositions
WO2009085314A8 (en) Compositions and methods for treating diseases of the nail
BRPI0517313A (en) oil-containing composition, consumable article, method for imparting, enhancing, enhancing or modifying properties, process for preparing a composition, and oil solubilization system
WO2009080659A3 (en) O/w emulsions containing a hydrophobic modified inulin and at least one thickening polysaccharide of plant origin
BR112015004185A2 (en) aerosol antiperspirant compositions, products and methods
WO2007017196A3 (en) Oil-in-water emulsions
WO2011069629A3 (en) Pharmaceutical composition comprising oligopeptides, preferably cilengitide
MY186442A (en) High internal phase water-in-oil type cosmetic composition
AR059210A1 (en) ANTITRANSPIRING COMPOSITIONS
WO2008140065A3 (en) Emulsion-containing composition, and method of preventing coagulation of polyphenol compound
WO2007059888A3 (en) Oil-in-water emulsions based on special emulsifiers
TW200701992A (en) Lignane compound-containing oil-in-water emulsion and composition comprising the same
WO2008070141A3 (en) Compositions for delivery of therapeutic agents
WO2009065946A3 (en) Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08852749

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2940/CHENP/2010

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2010125505

Country of ref document: RU

WWE Wipo information: entry into national phase

Ref document number: 2008852749

Country of ref document: EP